Wedbush Downgrades Cross Country Healthcare to Neutral, Lowers Price Target to $13.25

Benzinga Newsdesk www.benzinga.com Negative 91.7%

Neg 91.7% Neu 0% Pos 0%

Wedbush analyst Michael Piccolo downgrades Cross Country Healthcare (NASDAQ:CCRN) from Outperform to Neutral and lowers the price target from $15 to $13.25.